Cerus Corporation (NASDAQ:CERS) has announced that it will publish the financial results for it’s first quarter of fiscal 2010 on Thursday, April 29, 2010. The results will be released after the close of the stock market that day on the company’s Investor Relations site, http://investor.cerus.com/.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
A conference call will follow the release at 4:15 pm ET that afternoon. Cerus’ management will review the financial results during the call, providing the company’s business overview and outlook. Those interested may hear the call via webcast on the company’s Investor Relations site or by dialing 877.407.0782, or 201.689.8567 for international callers.
Cerus Corporation, is a biomedical products company focused on commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT system is designed to inactivate blood-borne pathogens in donated blood components intended for transfusion. The Company markets the INTERCEPT system for both platelets and plasma in Europe and the Middle East. Cerus is also pursuing regulatory approvals in the United States and other countries. The INTERCEPT red blood cell system is in clinical development.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
